SAVIENT PHARMACEUTICALS INC — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b58afcd2-0d7d-4a79-afd1-b52b309d22e8/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2012 | $-118.3M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-136648 |
| FY 2011 | $-102.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-089563 |
| FY 2010 | $-73.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-11-051607 |
| FY 2009 | $-90.9M | 2009-01-01 – 2009-12-31 | evidence 0001193125-11-051607 |
| FY 2008 | $-84.2M | 2008-01-01 – 2008-12-31 | evidence 0001193125-11-051607 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SAVIENT PHARMACEUTICALS INC — all facts · Revenue · Operating Income